GlassScriptPhysician profile
Jennifer C Stull
NPI 1457395055
$2,072.12
in general payments reported to CMS, 2019-2025
20 companies · $684 in 2025
The $684 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $103 · 2021: $200 · 2022: $147 · 2023: $422 · 2024: $517 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $610.86 | 2020-2025 | Veozah |
| Pfizer INC. | $395.63 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $229.58 | 2023-2025 | Myfembree |
| Novo Nordisk INC | $210.32 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Smith+Nephew, INC. | $89.43 | 2024-2025 | Grafix Pl, Stravix, Stravix Mesh |
| Exact Sciences Corporation | $67.23 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $66.01 | 2023-2024 | Jardiance, Zepbound, Emgality |
| Myovant Sciences INC. | $64.51 | 2022 | |
| Amgen INC. | $55.32 | 2020-2021 | |
| Abbvie INC. | $46.29 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.29 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.64 | 2021-2025 | Jardiance, Synjardy |
| Axsome Therapeutics, INC. | $26.28 | 2025 | Auvelity |
| Organon LLC | $22.04 | 2023 | Nexplanon |
| Abbott Laboratories | $21.73 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $20.92 | 2025 | Vivitrol |
| Hologic Sales and Service, LLC | $20.23 | 2024 | Aptima |
| Becton, Dickinson and Company | $15.04 | 2024 | Bd Onclarity |
| Teva Pharmaceuticals USA, INC. | $14.81 | 2021 | |
| Amarin Pharma, INC. | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.